Followers of the rapidly emerging literature in this area will likely find themselves best positioned to address these and other questions about optimal management of psychotropic-induced weight gain for the patients they treat
Ian Patton, director of advocacy and public engagement for Obesity Canada, called the approvals "exciting." Patton, who has lived with obesity most of his life, told CTV News that effective, evidence-based treatment options have long been scarce
Once an individual stops taking Semaglutide GLP-1, it is possible that they may regain some or all of the weight lost during the treatment
It's a tool to support weight management, not a standalone solution
Ozempic is the brand name for semaglutide, and according to Gervacio, its the most popular choice since it has shown the most promise for weight loss